Abstract:Background There are insufficient data to guide the appropriate use of red blood cell transfusion in patients with anemia and acute myocardial infarction (MI). Purpose To combine individual patient data from randomized clinical trials evaluating restrictive versus liberal transfusion strategies in patients with acute MI and anemia to generate precise estimates of treatment effects. Methods We searched all major databases to identify trials comparing restrictive versus liberal transfusion strategies in patients with acute MI and anemia (Hgb < 10 g/dl). We included studies that allocated participants to a liberal transfusion strategy that maintained hemoglobin greater than 10 g/dL or a restrictive transfusion strategy in which transfusion was administered if hemoglobin concentration was less than 8 g/dL. The primary outcome was a composite of 30-day death or MI. Secondary outcomes included 30-day death, 30-day cardiac death, and 6-month death. One-stage individual patient data meta-analyses were performed using a multilevel generalized linear model accounting for the clustering of patients within trials. Results We included 4311 participants from four trials. The primary outcome occurred in 334 patients (15.4%) in the restrictive and 296 patients (13.8%) in the liberal strategy (relative risk (RR) 1.13, 95% confidence interval (CI), 0.97 to 1.30) (figure 1). Death at 30-days occurred in 201 patients (9.3%) in the restrictive and 174 patients (8.1%) in the liberal strategy (RR 1.15; 95% CI, 0.95 to 1.39). Cardiac death at 30 days occurred in 5.5% in the restrictive strategy compared to 3.7% in the liberal strategy (RR 1.47; 95% CI, 1.11 to 1.94). Heart failure and thromboembolism occurred slightly more frequently in the liberal transfusion strategy group. Death at six months was higher in the restrictive (20.5%) compared to the liberal strategy (19.1%) (hazard ratio (HR) 1.08; 95% CI 1.05 to 1.11) (figure 2). The HR for cardiac death at 6 months was higher with a restrictive than liberal strategy (HR 1.38; 95% CI 1.08 to 1.76). In contrast, the HR for non-cardiac death at 6 months was lower with a restrictive than a liberal transfusion strategy (HR 0.89; 95% CI 0.84 to 0.94). Adjustment for baseline characteristics minimally changed the relative risk. Results for subgroups were similar except in patients without a history of renal failure whose risk of death or MI was increased with a restrictive strategy (RR 1.19; 95% CI, 1.01 to 1.39). Conclusions Pooled data from randomized trials found no significant differences for the primary outcome 30-day death or MI, but risk of cardiac death at 30 days and all cause death at 6 months was higher with a restrictive transfusion strategy. Given most outcomes favored liberal transfusion, and the risks from liberal transfusion were low, it may be prudent to use a liberal transfusion strategy in patients with acute MI and anemia.

Restrictive Versus Liberal Transfusion in Symptomatic Coronary Artery Disease and Myocardial Infarction: A Meta-Analysis of Randomized Controlled Trials

Efficacy and safety of restrictive versus liberal blood transfusion strategies in acute myocardial infarction and anemia: a systematic review and meta-analysis of randomized controlled trials

Restrictive versus liberal blood transfusion strategies in patients with myocardial infarction and anemia: individual patient data meta-analysis of randomized trials

Restrictive or Liberal Transfusion Strategy in Myocardial Infarction and Anemia

Liberal versus restrictive transfusion strategies in acute myocardial infarction: a systematic review and comparative frequentist and Bayesian meta-analysis of randomized controlled trials

Restrictive and liberal red cell transfusion strategies in adult patients: reconciling clinical data with best practice

Restrictive vs Liberal Blood Transfusions for Patients with Acute Myocardial Infarction and Anaemia by Heart Failure Status: An RCT Subgroup Analysis

A liberal blood transfusion strategy is safe in patients with myocardial infarction, anemia, and heart failure: lessons from MINT

Restrictive Versus Liberal Transfusion in Patients with Type 1 or Type 2 Myocardial Infarction: A Prespecified Analysis of the Myocardial Ischemia and Transfusion (MINT) Trial

Transfusion in Anemic Patients with Acute Coronary Syndromes: A Population-Based Cohort Study

Transfusion strategy trials excluding patients transfused outside the trial study period are more likely to report a trend favouring restrictive strategies: a meta-analysis

Restrictive versus liberal transfusion strategy for red blood cell transfusion: systematic review of randomised trials with meta-analysis and trial sequential analysis

[Comparison of Clinical Outcomes in Very Low Birth Weight Infants with Anemia by Different Transfusion Strategies].

Hemoglobin-based Transfusion Strategies for Cardiovascular - and Other Diseases: Restrictive, Liberal, or Neither?

Transfusion Strategy in Myocardial Infarction and Anemia

To transfuse or not transfuse: an intensive appraisal of red blood cell transfusions in the ICU

Restrictive versus liberal strategy for red blood-cell transfusion in hip fracture patients: A systematic review and meta-analysis.

Restrictive Versus Liberal Strategy for Red Blood-Cell Transfusion: A Systematic Review and Meta-Analysis in Orthopaedic Patients

Comparison of liberal versus restrictive transfusion strategies after hip surgery in patients with coronary artery disease: a post hoc analysis of the FOCUS trial

Efficacy of restrictive versus liberal transfusion strategies in patients with traumatic brain injury: a systematic review and meta-analysis of randomized controlled trials

Blood transfusion and ischaemic outcomes according to anemia and bleeding in patients with non-ST-segment elevation acute coronary syndromes: Insights from the TAO randomized clinical trial